Medtronic Launches Mazor X Stealth Edition for Robotic-Assisted Spine Surgery

Co-developed by Medtronic and the recently acquired Mazor Robotics, the system represents a unique marriage between robotics and navigation.

Just four months after first announcing its acquisition of Mazor, Medtronic has launched the Mazor X Stealth Edition for spine surgery. The system offers a fully-integrated procedural solution for surgical planning, workflow, execution, and confirmation, the company noted.

The first commercial use of the system was at Norton Healthcare in Louisville, KY and Reston Hospital Center in Reston, VA.

“It is rare that huge sectors of technology such as robotics and navigation merge into a sole platform as found in the Mazor X Stealth Edition,” said Jeffrey Gum, MD, an orthopedic spine surgeon at Norton Leatherman Spine. “Combined, these may provide more predictable and reliable execution of our procedure workflows. Computerized surgical planning, 3D assessment of spine anatomy, robotic guidance, and live navigation feedback are designed to provide a higher degree of accuracy throughout the surgical procedure.”

Co-developed between Medtronic and the recently acquired Mazor Robotics, the company said the Mazor X Stealth Edition incorporates Stealth software technology into the Mazor X robotic-assisted surgery platform to deliver workflow predictability and flexibility through real-time image guidance, visualization, and navigation informed by interactive 3D planning and information systems.

“The marriage of robotics and navigation represents the future of computerized planning and execution in spine surgery. Robotics and navigation have both been shown to improve accuracy and precision in spine surgery,” said Christopher Good, MD, spine surgeon at Reston Hospital Center, director of Scoliosis & Spinal Deformity and president of The Virginia Spine Institute. “The Mazor X Stealth Edition is a revolutionary new technology that uses cutting-edge software to plan the surgical procedure, then uses a robotic arm to guide implants and instruments through the steps of the surgical procedure with precision, while simultaneously using real-time imaging feedback to ensure the plan is being carried out as desired.”

The Mazor X Stealth Edition was cleared by FDA in November 2018. The system is now available in the United States and is expected to launch in key regions throughout the year.

By Amanda Pedersen | MD+DI

Image Credit: Medtronic

READ MORE

About Peter Coffaro 510 Articles
Peter Coffaro is a growth-driven and strategic executive with over 25 years of progressive management success in the medical device industry. With a proven track record and recognized expertise, Peter has established himself as one of the top influencers in medical sales, as acknowledged by prestigious publications such as the World Journal of Orthopedics, Exponential Healthtech, and MedReps.com. Throughout his career, Peter has accumulated 10 years of combined sales management experience, excelling in various roles including Director, General Manager, Distributor, and Vice President. He has worked for industry-leading orthopedic companies such as Zimmer, DePuy, and Stryker, solidifying his deep knowledge and network within the field. Peter’s passion for innovation and emerging technologies led him to found OrthoFeed, an award-winning blog covering digital orthopedic news and emerging medical technologies. Through this platform, he stays at the forefront of the industry and contributes to the dissemination of valuable insights. Peter is a three-time Hall of Fame award winner at Johnson and Johnson, demonstrating his exceptional contributions and impact on the organization. His expertise extends to areas such as organizational development, business development, sales management, digital marketing, and professional education. Peter earned a B.S. degree in Biology and Chemistry from Northern Illinois University, further complementing his comprehensive understanding of the medical field. With his wealth of experience, strategic mindset, and dedication to advancing healthcare, Peter Coffaro is a valuable asset and leader in the medical device industry.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.